Livzon Pharmaceutical Group has been identified as an investor by MIT spinout Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.
GV has contributed to a $92m series B for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.
DMG Mori, an existing customer of MIT spinout Tulip, has contributed to a round that closed at $39.5m, alongside Vertex Ventures, NEA and Pitango.
ETH Zurich’s Versantis picked up series B funding from Zürcher Kantonalbank among other returning investors to bring its total to $20.6m.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Immonogenomics blood test developer OncoCell, a Harvard Medical School spinout, has increased its total funding to $30m.
Institut Mérieux has returned for a $26.5m round for surgical technology developer Keranova, having previously supported a $4.6m round three and a half years ago.
MIT-founded robotic interior design developer Ori found support from Sidewalk Labs and Ingka Group as it looks to deliver full robotic interiors in partnership with architects and property developers.